AbbVie CEO Richard Gonzalez's 2020 pay rises 11% to $24M
AbbVie reports 2020 executive compensation
By ExecPay News
Published: March 22, 2021
AbbVie reported fiscal year 2020 executive compensation information on March 22, 2021.
In 2020, five AbbVie executives received on average a compensation package of $17M, a 22% increase compared to previous year.
Average pay of disclosed executives at AbbVie
Richard A. Gonzalez, Chief Executive Officer, received $24M in total, which increased by 11% compared to 2019. 49% of Gonzalez's compensation, or $12M, was in stock awards. Gonzalez also received $2.2M of change in pension value and nonqualified deferred compensation earnings, $4.9M in non-equity incentive plan, $2.8M in option awards, $1.7M in salary, as well as $760K in other compensation.
For fiscal year 2020, the median employee pay was $155,772 at AbbVie. Therefore, the ratio of Richard A. Gonzalez's pay to the median employee pay was 154 to one.
Laura J. Schumacher, Chief Legal Officer, received a compensation package of $17M, which increased by 13% compared to previous year. 34% of the compensation package, or $5.8M, was in stock awards.
Carlos Alban, Chairman, earned $17M in 2020, a 17% increase compared to previous year.
Robert A. Michael, Chief Financial Officer, received $13M in 2020, which increases by 54% compared to 2019.
Michael E. Severino, Chairman, earned $13M in 2020, a 41% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 22, 2021.